Skip to content
healthcare.dev

Saxagliptin and Metformin

NDC 0378-8175, saxagliptin and metformin, tablet, film coated, extended release, from Mylan Pharmaceuticals Inc..

Product NDC
0378-8175
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205981
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-8175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE5 mg/1
  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
0378-8175-930037881759330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-8175-93)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cbf8677c-cafe-48bc-8844-0cc6547886bd

Use it

Look up 0378-8175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-8175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-8175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.